December 22, 2005
Schering-Plough Animal Health launches new website for AQUAFLOR® in US
Schering-Plough Animal Health Corporation has launched a new website to keep the US aquaculture industry abreast of the latest developments with AQUAFLOR® (florfenicol), the first antibiotic approved for use on US fish farms in more than 20 years. The site can be accessed at www.AQUAFLOR-USA.com
Produced specifically for the US market, www.AQUAFLOR-USA.com includes a newsroom section, where the industry can access educational articles about aquatic disease management and the latest announcements concerning the product. The newsroom section also features company news releases and AquaFAQs, a new series of question-and-answer documents designed to answer the most frequently asked questions about the product.
Producers can also use the website to access HTML and downloadable PDF versions of product literature, as well as a handbook on using Veterinary Feed Directive (VFD) drugs, an exclusive status the US Food and Drug Administration assigned to AQUAFLOR and to all new in-feed drugs to ensure correct usage and long term effectiveness. VFD forms required by FDA are also available for downloading.
The site's scientific articles section features a downloadable PDF file of the AQUAFLOR monograph, which summarises all major US trials conducted to date to support the product's use in catfish, as well as links to several technical articles presented by scientists at industry meetings in recent years. An industry links page allows quick access to additional information from industry support services and the news media serving US aquaculture.
AQUAFLOR Type A Medicated Article is a fast-acting, broad-spectrum, highly palatable antibiotic premix developed specifically for aquaculture. It has been used worldwide to treat highly infectious bacterial diseases in salmon, trout and other farm-raised aquatic species. It was recently approved in the United States for controlling mortality in catfish due to enteric septicemia (ESC) associated with Edwardsiella ictaluri. Schering-Plough Animal Health is pursuing additional claims for use in other farm-raised aquatic species produced in the United States.
Schering-Plough Animal Health Corporation is the worldwide animal health business of Schering-Plough Corporation of Kenilworth, New Jersey. Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, veterinarians, patients and customers served by its more than 30,000 people around the world. The company is based in Kenilworth, NJ, and its website is www.schering-plough.com
AQUAFLOR is a registered trademark of Schering-Plough Veterinary Corporation.
